x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dishing The Science with Dr. Sue

Dr. Sue Pedersen

Thanks for tuning in! I"m a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I"m also certified as a Diplomate of the American Board of Obesity Medicine.Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I"m here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixed in

health & fitness medicine

All Episodes

7:39

GLP-1 in a pill for weight loss - pinning down where...

Dishing The Science with Dr. Sue ·

2025/09/22

While we now have several injectable GLP-1s based treatments for weight management around the world [liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound/Mounjaro)], there are no GLP-1s currently available in a pill format for obesity treatment. But that is likely soon to change, backed by a whirlwind of data that have come out around orforglipron and oral semaglutide this week. What will this mean for people seeking weight management treatment?Learn more:

en-us

6:11

Does everyone with type 2 diabetes need to be...

Dishing The Science with Dr. Sue ·

2025/09/18

Two out of three people with type 2 diabetes have 'fatty liver disease' (now called MASH/MASLD). Should everyone with prediabetes or type 2 diabetes be screened? Find out what the brand new Diabetes Canada Guidelines say here!Learn more: https://drsue.ca/2025/09/does-everyone-with-type-2-diabetes-need-to-be-screened-for-mash-masld-fatty-liver-what-the-new-diabetes-canada-guidelines-recommend/Any medical discussion on this podcast is intended to be of a general nature only, and is intended

en-us

3:51

Could metformin improve knee osteoarthritis pain?

Dishing The Science with Dr. Sue ·

2025/09/08

Metformin has lots of benefits, including a reduction in inflammation. Is the reduction in inflammation enough to reduce pain in knee osteoarthritis? Learn more: https://drsue.ca/2025/09/could-metformin-improve-knee-osteoarthritis-pain/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you

en-us

5:11

Do GLP1 based weight management medications benefit...

Dishing The Science with Dr. Sue ·

2025/09/02

Can semaglutide (Wegovy), tirzepatide (Mounjaro/Zepbound), or liraglutide (Saxenda) benefit liver health - and what did we recommend in our new 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines? Find out here!Learn more: https://drsue.ca/2025/08/do-glp1-based-weight-management-medications-benefit-liver-health/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical

en-us

5:29

What happens if you stop weight management...

Dishing The Science with Dr. Sue ·

2025/08/25

Some people on weight management medication may want to stop treatment because of cost, or perhaps because they want to again try 'doing it on their own'. What do our new Obesity Canada 2025 Clinical Practice Guidelines recommend on this topic?Learn more: https://drsue.ca/2025/08/what-happens-if-you-stop-weight-management-medication-and-what-do-our-new-obesity-canada-guidelines-advise/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a

en-us

4:20

OBESITY CANADA 2025 PHARMACOTHERAPY GUIDELINES: WHAT...

Dishing The Science with Dr. Sue ·

2025/08/20

In our NEW 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines, we identified many existing gaps where data is lacking. Where did our Guidelines leave us wanting for more? Where is more research needed? Find out here!Learn more: https://drsue.ca/2025/08/obesity-canada-2025-pharmacotherapy-guidelines-what-couldnt-we-answer/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give

en-us

5:20

Can weight loss medications improve erectile...

Dishing The Science with Dr. Sue ·

2025/08/20

Erectile dysfunction (ED) is common in men with elevated weight. Can weight loss medications improve ED?Learn more: https://drsue.ca/2025/08/can-weight-loss-medications-improve-erectile-dysfunction-ed/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician

en-us

4:51

OBESITY CANADA PHARMACOTHERAPY clinical practice...

Dishing The Science with Dr. Sue ·

2025/08/20

As the lead author, I am thrilled to ANNOUNCE publication of our long-awaited 2025 Obesity Canada Clinical Practice Guidelines! Includes 13 recommendations, a brand new Decision Tool&Table to guide in the choice of medication, Key Messages for Health Care Professionals and Key Messages for People With Obesity. ENJOY!! Learn more: https://drsue.ca/2025/08/obesity-canada-pharmacotherapy-clinical-practice-guidelines-2025-published/Any medical discussion on this podcast is intended to be of a

en-us

5:56

How does Mounjaro stack up for cardiovascular...

Dishing The Science with Dr. Sue ·

2025/08/05

In choosing the best GLP1-based medication for our patients with type 2 diabetes at high risk of cardiovascular disease, guidelines recommend choosing one that has proven reduction in risk of CV events in cardiovascular outcome trials (CVOTs). High level results just released on Mounjaro's SURPASS CVOT study tell us how mounjaro stacks up. Read on to find out!Learn more: https://drsue.ca/2025/08/how-does-mounjaro-stack-up-for-cardiovascular-protection-the-surpass-cvot-results/Any medical

en-us

3:45

Can creatine supplements preserve muscle during...

Dishing The Science with Dr. Sue ·

2025/07/28

Can creatine supplements preserve muscle during weight loss? Learn more: https://drsue.ca/2025/07/can-creatine-supplements-preserve-muscle-during-weight-loss/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation

en-us

4:10

Sleep is a nutrient!

Dishing The Science with Dr. Sue ·

2025/07/23

We often talk about sleep as a luxury in our busy lives. But what if we redefined sleep entirely? What if we thought of sleep like an essential vitamin – non-negotiable, restorative, and vital? It’s time we start seeing sleep as a nutrient.Learn more: https://drsue.ca/2025/07/sleep-is-a-nutrient/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to

en-us

4:34

Could GLP1 weight loss/diabetes medications benefit...

Dishing The Science with Dr. Sue ·

2025/07/14

As we gain 20+ years of experience with GLP1-based treatment, I continue to be fascinated by the diversity of potential benefits that we are finding in clinical trials and in clinical practice. A fascinating article was recently published reviewing the potential benefits of GLP1-based medication to skin conditions. Find out more here!Learn more: https://drsue.ca/2025/07/could-glp1-weight-loss-diabetes-medications-benefit-skin-conditions-like-psoriasis-or-hidradenitis-suppurativa/Any medical

en-us

4:44

Will once-a-month weight loss medication be a next...

Dishing The Science with Dr. Sue ·

2025/06/30

Could the next generation of weight management medications include treatments given just once a month? Find out more here!Learn more: https://drsue.ca/2025/06/will-once-a-month-weight-loss-medication-be-the-next-big-step-forward/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should

en-us

8:33

Wegovy Plus Amylin: CagriSema weight management...

Dishing The Science with Dr. Sue ·

2025/06/23

I was honored to present results of CagriSema - Wegovy+Amylin (cagrilintide) - as an up-and-coming weight managment medication at the American Diabetes Association meeting yesterday, with simultaneous publication of our results in the New England Journal of Medicine. Find out more here!Learn more: https://drsue.ca/2025/06/wegovy-plus-amylin-cagrisema-weight-management-results-revealed/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian

en-us

3:48

Could risk of heart attack and stroke risk rise...

Dishing The Science with Dr. Sue ·

2025/06/23

Diabetes is a risk factor for cardiovascular (CV) disease. But could the risk of heart attack and stroke be elevated, even DECADES before the diagnosis of type 2 diabetes is made? Find out more here!Learn more: https://drsue.ca/2025/06/could-risk-of-heart-attack-and-stroke-risk-rise-decades-before-type-2-diabetes-diagnosis/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical

en-us

4:46

Mazdutide: First phase 3 GLP1/glucagon dual agonist...

Dishing The Science with Dr. Sue ·

2025/06/02

Could GLP1 and glucagon work together to provide weight loss benefits and improvement to metabolic and liver health? Find out about the results of the first phase 3 study of a dual GLP1/glucagon receptor agonist (mazdutide) here! Learn more: https://drsue.ca/2025/06/mazdutide-first-phase-3-glp1-glucagon-dual-agonist-weight-management-results/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give

en-us

4:59

What do people list as Top 3 risks of weight...

Dishing The Science with Dr. Sue ·

2025/06/02

When we as doctors think about risks of any medication, the first thing that comes to mind is the potential for side effects. But when I ask my patients what they perceive as potential risks of treatment, often the answer is something else entirely. What does a recent publication tells us about what is on people's minds? Learn more: https://drsue.ca/2025/05/what-do-people-list-as-top-3-risks-of-weight-management-medication-and-none-of-them-are-side-effects/Any medical discussion on this

en-us

4:49

Zepbound (Mounjaro) for weight management approved in...

Dishing The Science with Dr. Sue ·

2025/05/20

Tirzepatide, which has been approved in Canada as a diabetes medication (Mounjaro) since 2022, received Health Canada approval for weight management this week (called Zepbound). What do you need to know?Learn more: https://drsue.ca/2025/05/zepbound-mounjaro-tirzepatide-for-weight-management-approved-in-canada/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to

en-us

5:43

Zepbound/Mounjaro and Wegovy face off!

Dishing The Science with Dr. Sue ·

2025/05/15

Zepbound/Mounjaro and Wegovy face off in a head-to-head trial. How did they compare? Learn more: https://drsue.ca/2025/05/zepbound-mounjaro-and-wegovy-face-off/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own

en-us

3:44

Can weight loss with obesity medication reduce risk...

Dishing The Science with Dr. Sue ·

2025/04/30

For a person living with obesity who has had already had a hip or knee replaced, can weight loss with obesity medication reduce the risk of needing a revisional surgery?Learn more: https://drsue.ca/2025/04/can-weight-loss-with-obesity-medication-reduce-risk-for-revisional-surgery-after-hip-or-knee-replacement/Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to

en-us

95 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Podcasts Archives - Extreme Health Radio

Justin Stellman

Oncology for the Inquisitive Mind

Michael Fernando and Josh Hurwitz

Good Sleep: Positive Affirmations

Optimal Living Daily | Sleepy Meditation

Johannes Hansen Podcast

Johannes Hansen